Julie Hambleton
CIK 1578771 · SVP, Chief Medical Officer · last filed 2025-08-14
Julie Hambleton is a SVP, Chief Medical Officer who has filed 35 SEC Form 4 insider transactions across 5 companies since 2014. The most recent filing, for IGMS, was dated Aug 14, 2025. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $84.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$84.3K
5
35
-$2.13M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IGM Biosciences, Inc. (IGMS) Delisted | Director | 0 | $1.27 | $0 | -$360.3K | 11 | 2025-08-14 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 0 | $46.99 | $0 | -$1.09M | 12 | 2025-07-02 |
| ERAS | Director | 6,000 | $14.05 | $84.3K | $96.0K | 5 | 2025-06-26 |
| IDYA | SVP, Chief Medical Officer | — | $28.98 | — | $0 | 1 | 2020-02-25 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | EVP & Chief Medical Officer | 95,983 | $38.00 | $3.65M | -$778.2K | 6 | 2015-11-13 |
Recent Filings
35 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-14 | IGM Biosciences, Inc. (IGMS) Delisted | Disp (D) | −2,000 | $0 | EDGAR |
| 2025-07-02 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Disp (D) | −14,155 | $0 | EDGAR |
| 2025-06-26 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2025-05-15 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +10,060 | $0 | EDGAR |
| 2025-02-12 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Mixed | — | -$285.7K | EDGAR |
| 2024-07-29 | IGM Biosciences, Inc. (IGMS) Delisted | Mixed | — | -$190.8K | EDGAR |
| 2024-06-21 | ERAS | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Sell (S) | −4,648 | -$186.0K | EDGAR |
| 2024-05-17 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +4,095 | $0 | EDGAR |
| 2024-03-14 | IGM Biosciences, Inc. (IGMS) Delisted | Grant (A) | — | $0 | EDGAR |